The higher plasma α2-MG, SLPI and ACT levels reported in AAT deficiency subjects at younger ages were previously attributed to an unidentified compensatory mechanism that protects lung tissue against proteolytic injury under conditions of AAT depletion. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.